Learning Center

Learning Center

Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Includes Multiple Live Events. The next is on 12/03/2023 at 10:00 AM (EST)

    Course Date: December 3, 2023. This advanced densitometry course focuses on how vertebral fracture imaging advances the diagnosis and treatment of patients at risk of osteoporotic fractures. It emphasizes the importance of vertebral fractures in the clinical management of osteoporosis, including recognition of lateral spine images of a normal spine, vertebral fractures, and other findings that may be confused with vertebral fractures. Fracture recognition, analysis, and best-practice patient positioning are detailed to ensure ideal image acquisition, interpretation, and reporting.

    Course Date

    December 3, 2023

    Course Description

    This advanced densitometry course focuses on how vertebral fracture imaging advances the diagnosis and treatment of patients at risk of osteoporotic fractures. It emphasizes the importance of vertebral fractures in the clinical management of osteoporosis, including recognition of lateral spine images of a normal spine, vertebral fractures, and other findings that may be confused with vertebral fractures.  Fracture recognition, analysis, and best-practice patient positioning are detailed to ensure ideal image acquisition, interpretation, and reporting. It is recommended, but not required, that registrants attend the Osteoporosis Essentials/Quality Bone Densitometry Course (Clinician or Technologist) prior to attending the VFR course


    Target Audience

    The content is designed for healthcare providers responsible for reading and interpreting DXA scans, including specialists and generalists working in family medicine, general and internal medicine, rheumatology, endocrinology, obstetrics/gynecology, radiology, nuclear medicine, physical and occupational therapy, and research. The course is also appropriate for technologists.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    1. Summarize best-practice methods utilized to recognize vertebral fractures on lateral spine images.
    2. Describe non-fracture abnormalities that may appear on a spine image.
    3. Identify characteristics of high-quality densitometric lateral spine images. 
    4. Identify the appropriate complementary technologies to complete vertebral fracture assessment. 
    5. Cite indications for VFA as stated in the 2015 ISCD Official Positions.

    Method of Participation

    This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on December 3, 2023. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit. 


    Rates

    image

    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ACCME Accreditation Statement:

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this live educational activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ASRT Credit Designation: 

    This activity has been approved by ASRT for 4.5 Category A continuing education credits.

    Date of Original Release and most recent Review or Update: This activity was most recently reviewed and released on July 25, 2022.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

    Schedule - December 3, 2023 - All times eastern (NYC/USA)

    image


    John Schousboe, MD, PhD, CCD

    Director, Park Nicollet Bone Densitometry Center; Consultant Rheumatologist, Park Nicollet Clinic; Research Investigator, HealthPartners Institute

    Dr. Schousboe is a rheumatologist and health services researcher who directs the bone densitometry center of Park Nicollet Clinic, a large integrated health care delivery system in Minneapolis, MN. He is an a Past President of the International Society for Clinical Densitometry (ISCD) and a Fellow of the American Society for Bone and Mineral Research (ASBMR). During a 16-year research career he has been an author on 200 peer-reviewed publications, the far majority of which have been in the field of diagnosis and management of osteoporosis. His contributions to science include development of a cost-effectiveness model that was used to conduct studies of the cost-effectiveness of bone densitometry in men and subgroups of older women and men defined by prevalent vertebral fracture, bone turnover marker levels, and bone density level; studies of the accuracy, prevalence, and clinical impact of vertebral fracture recognition on bone density lateral spine images; studies of medication adherence to osteoporosis therapies; studies of the identification and clinical significance of abdominal aortic calcification on lateral bone density spine images; and predictors of health care utilization and costs using Medicare Claims data.

    No Financial Relationships to Disclose 

    E. Michael Lewiecki, MD, FACP, FACE, CCD

    Director

    New Mexico Clinical Research & Osteoporosis Center, Inc.

    E. Michael Lewiecki, MD, CCD, FACP, FACE, FASBMR, is Director of New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health TeleECHO at University of New Mexico Health Sciences Center in Albuquerque, NM. His is a consultant in osteoporosis and metabolic bone disease, supervisor and interpreter of bone density studies, and an educator with a special interest in the evaluation and treatment of osteoporosis and metabolic bone diseases. He has been principal investigator for many osteoporosis clinical trials and is author of over 300 publications in peer-reviewed medical journals, as well as books, book chapters, and online publications on osteoporosis. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD) and current president of the Osteoporosis Foundation of New Mexico (OFNM). He is an editor for Osteoporosis International, and is on the editorial boards of the Journal of Bone and Mineral Research and the Journal of Clinical Densitometry. He has received national and international awards that include the 2021 “Dr. John P. Bilezikian ISCD Global Leadership Award” and the 2021 “Lawrence G. Raisz Memorial Lecture Award” with the Bone Health & Osteoporosis Foundation. Dr. Lewiecki is the program director of the annual Santa Fe Bone Symposium, the flagship activity of the OFNM.

    Disclosures: Amgen (Self) : Consultant (Status: Ongoing), Research Support (Status: Ongoing), Speaker's Bureau / Teaching Engagements (Status: Ongoing); Radius (Self) : Research Support (Status: Ongoing)

    Course Planning Committee

    Tamara Vokes, MD, CCD No Financial Relationships to Disclose
    Brad Richmond, MD, FACR,CCD No Financial Relationships to Disclose
    John Schouseboe, MD, PhD, CCD No Financial Relationships to Disclose
    Harold Rosen, MD, CCD No Financial Relationships to Disclose
    Edwin Oei, MD, PhD No Financial Relationships to Disclose

    Course Content Reviewers

    Campbell Macgregor, CCD No Financial Relationships to Disclose
    Kelly Molinar-Kagan, RT(R)(M) CBDT No Financial Relationships to Disclose
    Monique Carroll, RT, CBDT No Financial Relationships to Disclose
    Merle Wigeson, MD No Financial Relationships to Disclose

    December 2023 Course Faculty

    John Schousboe, MD, PhD, CCD No Financial Relationships to Disclose
    E. Michael Lewiecki, MD, FACP, FACE, CCD No Financial Relationships to Disclose

    image

    Statement of Independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

  • Includes Multiple Live Events. The next is on 11/04/2023 at 10:00 AM (EDT)

    Course Date: November 4, 2023. This course focuses on increasing the knowledge and competence of clinicians and other healthcare professionals to help them successfully use DXA body composition analysis in the management of obesity, geriatric sarcopenia and other low muscle mass states, general health and pediatric skeletal disease. The inclusion of case studies will reinforce the knowledge gained and allow for application in the diagnosis, treatment and therapies of patients presenting with low bone mineral density.

    Course Date

    November 4, 2023

    Course Description

    This course focuses on increasing the knowledge and competence of clinicians and other healthcare professionals to help them successfully use DXA body composition analysis in the management of obesity, geriatric sarcopenia and other low muscle mass states, general health and pediatric skeletal disease. The inclusion of case studies will reinforce the knowledge gained and allow for application in the diagnosis, treatment and therapies of patients presenting with low bone mineral density.

    Target Audience

    The content is designed for healthcare providers responsible for reading and interpreting DXA scans, including specialists and generalists working in family medicine, general and internal medicine, rheumatology, endocrinology, obstetrics/gynecology, radiology, physical and occupational therapy, and research, as well as technologists.

    Learning Objectives

    After attending the course, participants should be better prepared to:

    1. Identify proper DXA technology for body composition analysis of fat, lean muscle and bone mass.
    2. List other methods of body composition analysis used in the clinical setting.
    3. Differentiate reference values and indices.
    4. Identify limitations of reference values and indices.
    5. Summarize scan acquisition for adult and pediatric patients.

    Method of Participation

    This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on November 4, 2023. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit. 

    Rates

    image


    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ACCME Accreditation Statement:

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this live educational activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ASRT Credit Designation: 

    This activity is pending ASRT approval.

    Date of Original Release and most recent Review or Update: This activity was most recently reviewed and released on July 25, 2022.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

    Schedule - November 4, 2023 - All times eastern (NYC/USA)
    image


    Adam Kuchnia

    Adam Kuchnia is an Assistant Professor at the University of Wisconsin-Madison in the Department of Nutritional Sciences and holds a joint appointment within the Department of Surgery at the University of Wisconsin School of Medicine and Public health. The overall goal of his laboratory is to use a translational research approach to understand the mechanisms involved in the pathogenesis and the clinical implications of myosteatosis (i.e. muscle quality), or the infiltration of fat within muscle tissue, in aging and age-related disease. He has expertise in various imaging modalities for the assessment of muscle and in protein/muscle metabolism. Currently, his research focuses on human nutrition, in vivo lean tissue/muscle imaging and ex vivo measures to assess muscle and metabolic dysfunction. Adam is particularly interested in novel applications to refine protein recommendations with the goal of preserving muscle mass and muscle quality, while preventing consequential outcomes seen in aging and age-related disease. His research also aims to develop novel, noninvasive methods to accurately detect muscle wasting and myosteatosis and monitor changes in skeletal muscle while optimizing therapeutic intervention throughout medical treatment and surgery, including chemotherapy/immunotherapy and transplantation.

    No financial relationships to disclose

    John Shepherd PhD, CCD

    Dr.

    Course Planning Committee

    Ian Entwistle No Financial Relationships to Disclose
    Karen Hind, PhD, No Financial Relationships to Disclose
    Gary Slater No Financial Relationships to Disclose
    Michelle Swainson, BSc, MSc, PhD No Financial Relationships to Disclose
    Greg Yardley, MSRS, RT(R), CBDT No Financial Relationships to Disclose

    Course Content Reviewers

    Suresh Kumar, MD, CCD No Financial Relationships to Disclose
    William Leslie, MD, FRCPC, MSc, CCD No Financial Relationships to Disclose
    Kelly Molinar-Kagan, RT(R)(M), CBDT No Financial Relationships to Disclose
    Vani Selvan, MD, CCD No Financial Relationships to Disclose

    November 2023 Course Faculty

    Adam Kuchina No Financial Relationships to Disclose
    Dr. John A. Shepherd, PhD, CCD Contracted Research- Hologic, Inc-Investigator Initiated Study; GE Healthcare-Investigator Initated Study; Ownership Interest-BodySpec-Stock Options for Scientific Advisory Board

    image

    Statement of independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

  • Includes Multiple Live Events. The next is on 10/28/2023 at 10:00 AM (EDT)

    Course Date: October 28, 2023. The Pediatric Bone Densitometry Course provides the most current research and best-practice techniques for obtaining and interpreting bone mineral density (BMD) measurements in children and adolescents. This educational program is designed to improve learner competence in the area of pediatric densitometry. Learners will have the opportunity to take the knowledge gained from this educational program and properly/consistently apply it to their professional practices.

    Course Date

    October 28, 2023

    Course Description

    The Pediatric Bone Densitometry Course provides the most current research and best-practice techniques for obtaining and interpreting bone mineral density (BMD) measurements in children and adolescents. This educational program is designed to improve learner competence in the area of pediatric densitometry. Learners will have the opportunity to take the knowledge gained from this educational program and properly/consistently apply it to their professional practices.


    Target Audience

    The content is designed for healthcare providers with an interest in skeletal health assessment, including specialists, generalists and technologists working in family medicine, general and internal medicine, endocrinology, rheumatology, obstetrics/gynecology, radiology, pediatrics, physical and occupational therapy, nuclear medicine and research.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    1. Identify the most appropriate and reproducible sites for densitometry in children and adolescents.
    2. Outline the corrections in DXA measurements that should be made when acquiring assessments in children and adolescents.
    3. Describe the uses of measurement tools for acquiring bone densitometry assessments including DXA, as well as those other than DXA.
    4. Summarize the elements that should be included in a DXA report for a child or adolescent.
    5. Recognize issues that arise in children with chronic disease(s) that many times arise in the skeletal assessment.

    Method of Participation

    This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on October 28, 2023. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit. 


    Rates

    image

    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ACCME Accreditation Statement:

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

     It is anticipated that this learning activity will be approved for a maximum 4 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ASRT Credit Designation: 

    It is anticipated that this activity will be approved for 4.50 Category A continuing education credits.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

    Dr. Neil Jacob Paloian

    Dr. Nina Ma, MD, CCD

    image

    Statement of Independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

  • Includes Multiple Live Events. The next is on 09/09/2023 at 10:00 AM (EDT)

    Course Date: September 9 & 10, 2023. The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.

    Course Date

    September 9 & 10, 2023.


    Course Description

    The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.


    Target Audience

    The course is most appropriate for those involved in the performance and interpretation of DXA scans and those managing patients with osteoporosis. It is open to MDs, PhDs, DOs, Nurse Practitioners, and Physician Assistants. Technologists may attend if they have previously taken the ISCD/IOF Osteoporosis Essentials for Technologists Course.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    • Describe appropriate clinical evaluation of patients at risk for fragility fracture.
    • Summarize the value and importance of quality bone densitometry for the diagnosis of osteoporosis, assessment of fracture risk, and monitoring of BMD. 
    • Recognize errors in DXA analysis and reporting. 
    • Explain new and emerging guidelines that provide evidence-based information regarding skeletal health. 
    • Describe the use of current and new pharmacologic therapies for the management and treatment of osteoporosis, including adverse effects.

    Method of Participation

    This activity will be offered live streamed via Zoom, allowing the learner to watch and ask questions in a live format on September 9 & 10, 2023. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

    Rates


    image


    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ACCME Accreditation Statement:

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this live educational activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

     Schedule - Day 1 - All times Eastern Standard Time (NYC/USA)
    image


     Schedule - Day 2 -All times Eastern Standard Time (NYC/USA)

    image


    Sarah L. Morgan, MD, RD, CCD

    Professor, Medical Director UAB Osteoporosis Clinic and DXA Facility

    University of Alabama at Birmingham

    Dr. Morgan is the Medical Director of the University of Alabama at Birmingham Osteoporosis Prevention and Treatment Clinic and the UAB Bone Densitometry (DXA) Service. The UAB DXA service is accredited by the International Society for Clinical Densitometry. She received degrees in Food and Nutrition and Dietetics and Food and Nutrition and Related Sciences at Iowa State University and completed medical school and an internal medicine internship and residency at the University of Iowa. She completed a Clinical Nutrition fellowship and a master’s degree in Clinical Nutrition at the University of Alabama at Birmingham. She currently is a Professor of Medicine and Nutrition Sciences in the Division of Clinical Immunology and Rheumatology. Dr. Morgan’s research interests are in the areas of folate and methotrexate metabolism in rheumatoid arthritis and bone densitometry and she participates in osteoporosis and DXA clinical trials in the UAB Osteoporosis Clinic. Dr. Morgan is s past President of the International Society for Clinical Densitometry and a past chair of the ISCD Education Council.

    Disclosures: No Financial Relationships to Disclose

    Steven M. Petak, MD, JD, MACE, FACP

    Division Head and Clinical Service Chief Endocrinology

    Houston Methodist Hospital

    Dr. Steven Petak is a clinical and academic endocrinologist in Houston, Texas.

    He is a past president of the American Association of Clinical Endocrinologists, the American College of Endocrinology (www.aace.com), and the International Society for Clinical Densitometry (www.iscd.org). He is an associate clinical professor at Weill-Cornell Medical College at the Houston Methodist Hospital and is the division head of endocrinology, diabetes and metabolism as well as service chief of endocrinology. He is a bone densitometry and endocrine consultant to NASA at the Johnson Space Center for about 13 years and has been a part of the bone summit planning long duration space missions. He is the secretary of the board of councilors of the Texas Medical Association (2015) and represents the Harris County Medical Society as vice-councilor.

    His awards include Master of the American College of Endocrinology, Yank Coble Public Service Award of the American College of Endocrinology, the ISCD Paul Miller Public Service Award, and ISCD Clinician of the Year. He has authored and co-authored articles, editorials and guidelines in endocrinology and reproductive medicine.

    He received his MD from the University of Illinois in Chicago and has his JD from the University of Houston (Magna cum Laude). He had his internship, residency, medical chief residency, and fellowship in endocrinology and metabolism at the University of Texas at Houston. He was at the Texas Institute for Reproductive Medicine and Endocrinology in Houston for about 26 years before joining the academic endocrine group at Methodist in May 2013. He is board certified in internal medicine as well as endocrinology and metabolism.

    Disclosures: Fees for Non-CME Services: Amgen, Alexion, Shire, Alexion 

    E. Michael Lewiecki, MD, FACP, FACE, CCD

    Director

    New Mexico Clinical Research & Osteoporosis Center, Inc.

    E. Michael Lewiecki, MD, CCD, FACP, FACE, FASBMR, is Director of New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health TeleECHO at University of New Mexico Health Sciences Center in Albuquerque, NM. His is a consultant in osteoporosis and metabolic bone disease, supervisor and interpreter of bone density studies, and an educator with a special interest in the evaluation and treatment of osteoporosis and metabolic bone diseases. He has been principal investigator for many osteoporosis clinical trials and is author of over 300 publications in peer-reviewed medical journals, as well as books, book chapters, and online publications on osteoporosis. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD) and current president of the Osteoporosis Foundation of New Mexico (OFNM). He is an editor for Osteoporosis International, and is on the editorial boards of the Journal of Bone and Mineral Research and the Journal of Clinical Densitometry. He has received national and international awards that include the 2021 “Dr. John P. Bilezikian ISCD Global Leadership Award” and the 2021 “Lawrence G. Raisz Memorial Lecture Award” with the Bone Health & Osteoporosis Foundation. Dr. Lewiecki is the program director of the annual Santa Fe Bone Symposium, the flagship activity of the OFNM.

    Disclosures: Amgen (Self) : Consultant (Status: Ongoing), Research Support (Status: Ongoing), Speaker's Bureau / Teaching Engagements (Status: Ongoing); Radius (Self) : Research Support (Status: Ongoing)

    Course Planning Committee

    Neil Binkley, MD, CCD, CBDT  Consulting Fee: Amgen; Contracted Research: Radius 
    Sarah Morgan, MD, RD< CCD No Financial Relationships to Disclose 
    Steven Petak, MD, JD, MACE, FACP, CCD Fees for Non-CME Services: Amgen, Alexion
    Christopher Shuhart, MD, CCD No Financial Relationships to Disclose
    S. Bobo Tanner, MD, CCD Consulting Fees: AMDA, CSL Behring, Radius, Ultragenyx; Fees for Non-CME Services: Regeneron, Sanofi/GENZYME; Contracted Research: Amgen 

    Course Content Reviewers

    Carolyn Crandall, MD, CCD No Financial Relationships to Disclose 
    Monique Carroll, RT, CBDT No Financial Relationships to Disclose 
    Brian Englander, MD No Financial Relationships to Disclose 
    Ranjodh Gill, MD, CCD No Financial Relationships to Disclose 
    Heidi Kecskemethy, MS Ed, RDN, CSP, CBDT No Financial Relationships to Disclose
    Adrian Lau, MD, FRCPC, MScCH, CCD No Financial Relationships to Disclose 
    Orhan Oz, MD, PhD, CCD  No Financial Relationships to Disclose

    June 2023 Course Faculty

    Sarah Morgan, MD, RD, CCD No Financial Relationships to Disclose
    Steven M. Petak, MD, JD, MACE, FACP Fees for Non-CME Services: Amgen, Alexion
    Gillian G. Woolridge, DO, CCD No Financial Relationships to Disclose

    image

    Statement of independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

  • Includes Multiple Live Events. The next is on 06/10/2023 at 10:00 AM (EDT)

    Course Date: June 10 & 11, 2023. The core elements of this program focus on performing quality DXA scans, dissecting the data, and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive, and informative. The course emphasizes technical excellence in the performance, analysis, and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.

    Course Date

    June 10 & 11, 2023.


    Course Description

    The core elements of this program focus on performing quality DXA scans, dissecting the data, and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive, and informative. The course emphasizes technical excellence in the performance, analysis, and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.


    Target Audience

    The course is most appropriate for those involved in the performance of DXA scans and open to any health professional performing these scans.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    1. Design and implement quality control and assurance practices
    2. Perform a precision assessment and appreciate the requirement for clinical care  
    3. Identify the anatomy relevant to clinical DXA scanning 
    4. Implement consistent and appropriate technical acquisition and analysis techniques  
    5. Perform a fracture risk assessment using FRAX 
    6. Provide DXA interpreters sufficient information for a high-quality DXA report 
    7. Understand how specific medical conditions and medications affect bone density 
    8. Demonstrate how to access features within the DXA software 
    9. Critically evaluate DXA scans to identify acquisition and analysis errors and implement resolution methods 
    10. Recognize how technical errors impact clinical interpretation and patient care

    Method of Participation

    This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on June 10 & 11, 2023. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

    ASRT Credit Notice

    This course is a renewal. If you have previously taken this course, you will not be able to claim ASRT again for this learning activity.

    Registration Fee

    image



    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ASRT Credit Designation: 

    This activity has been approved by ASRT for 13.0 Category A continuing education credits.

    Date of most recent Review or Update: This activity was most recently reviewed and renewed March 24, 2023.

    ASRT Credit Notice

    This course is a renewal. If you have previously taken this course, you will not be able to claim ASRT again for this learning activity.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

    Maureen A. Costello

    AAS, RT(R), CBDT

    Maureen has been a Radiologic Technologist for the past 25 years. As a diagnostic Rad. Tech., she specialized in Trauma and Surgical radiography at one of two Trauma Centers in the greater Chicago land area, and then moved into Orthopedic Radiography before moving onto DXA in 2003. She is the Lead Tech. At the University of Chicago Hospitals, Dept. of Endocrinology. While the bulk of her day consists of performing BMD’s, she is also responsible for QA/QC of equipment and reports, monitoring and performing multiple studies and on-site training of not only office staff but also tutorials for 4th year Med. Students. Maureen has been certified since 2003 and has been an instructor with the ISCD since 2007.


    Disclosure: No Financial Relationships to Disclose

    Lawrence G. Jankowski, CBDT

    Chief DXA Technologist/Research Coordinator

    Illinois Bone and Joint Institute, LLC

    Lawrence Jankowski is the chief DXA technologist and a research coordinator for Illinois Bone and Joint Institute, a multi-disciplinary 100+ physician practice with over 20 locations within Chicago and surrounding suburbs, specializing in orthopedic and rheumatologic health and sports performance and fitness. He started clinical imaging as a nuclear medicine technologist in 1978, performing both single- and dual- photon absorptiometry in beginning in 1987, and switched to DXA in 1990. He is also registered in radiology (limited), and is certified by the International Society for Clinical Densitometry (ISCD) first as a CDT in 1996, and then CBDT in 2001.

    In addition to his clinical and research duties, he is a technical instructor for the ISCD bone density courses, serves on the editorial board for the Journal of Clinical Densitometry, chairman of the Facility Accreditation Program, He has presented numerous posters on bone densitometry at scientific meetings, including the ASBMR, AAOS, NOF, as well as ISCD. Most recently, he served as task force chair for the 2019 Position Development Conference on cross-calibration and LSC determination in multiple scanner environments.

    Disclosure: No Financial Relationships to Disclose

    Anita Colquhoun, RTNM, MRT(N), CDT

    Charge Technologist

    Women's College Hospital

    Anita Colquhoun M.R.T.(N), CDT is the charge technologist in the Centre for Osteoporosis & Bone Health at the Women’s College Hospital in Toronto. Anita is a Nuclear Medical Technologist specialized in Bone Mineral Density (BMD). She has been working in the field of BMD since the early 1990s. Anita is an active member ISCD Technologist Faculty since 2000. She has served 2 terms on the Governing Board of the ISCD and is currently serving her third term as the Executive Secretary to the Board. As well as Chairing then Annual Meeting Committee from 2012-2016 Anita served and is still serving on several other committees within the ISCD. She has participated in a variety of research studies and has co-authored abstracts and papers. Anita has also co-written an on-line beginner BMD course as well as developed a competency profile and best practise in BMD for the Ontario Association of Medical Radiation Sciences.

    Disclosures: No relationships to disclose.

    Course Planning Committee

    JoAnn Caudill, RT(R)(M)(BD), CBDT  No Financial Relationships to Disclose 
    Anita Colquhoun, RTNM, MRT(N), CDT No Financial Relationships to Disclose 
    Larry G. Jankowski, CBDT No Financial Relationships to Disclose
    Greg Yardley, MSRS, RT(R), CBDT No Financial Relationships to Disclose
    Michelle Kochanski ,BSIT, RT(R), CBDT No Financial Relationships to Disclose 
    Maureen Costello, RT(R), AAS, CBDT No Financial Relationships to Disclose 
    Diane Krueger, BS, CBDT Consulting Fee: Amgen; Contracted Research: Radius

    Course Content Reviewers

    Carolyn Crandall, MD, CCD No Financial Relationships to Disclose 
    Monique Carroll, RT, CBDT No Financial Relationships to Disclose 
    Brian Englander, MD No Financial Relationships to Disclose 
    Ranjodh Gill, MD, CCD No Financial Relationships to Disclose 
    Heidi Kecskemethy, MS Ed, RDN, CSP, CBDT No Financial Relationships to Disclose
    Adrian Lau, MD, FRCPC, MScCH, CCD No Financial Relationships to Disclose 
    Orhan Oz, MD, PhD, CCD  No Financial Relationships to Disclose

    June 2023 Course Faculty

    Lawrence Jankowski, CBDT No Financial Relationships to Disclose
    Maureen Costello, RT(R), AAS, CBDT No Financial Relationships to Disclose
    JoAnn Caudill, RT(R)(M)(BD),CBDT No Financial Relationships to Disclose

    image

    Statement of Independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity.

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ASRT Credit Notice

    This course is a renewal. If you have previously taken this course, you will not be able to claim ASRT again for this learning activity.

  • Includes Multiple Live Events. The next is on 06/10/2023 at 10:00 AM (EDT)

    Course Date: June 10 & 11, 2023. The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.

    Course Date

    June 10 & 11, 2023.


    Course Description

    The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.


    Target Audience

    The course is most appropriate for those involved in the performance and interpretation of DXA scans and those managing patients with osteoporosis. It is open to MDs, PhDs, DOs, Nurse Practitioners, and Physician Assistants. Technologists may attend if they have previously taken the ISCD/IOF Osteoporosis Essentials for Technologists Course.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    • Describe appropriate clinical evaluation of patients at risk for fragility fracture.
    • Summarize the value and importance of quality bone densitometry for the diagnosis of osteoporosis, assessment of fracture risk, and monitoring of BMD. 
    • Recognize errors in DXA analysis and reporting. 
    • Explain new and emerging guidelines that provide evidence-based information regarding skeletal health. 
    • Describe the use of current and new pharmacologic therapies for the management and treatment of osteoporosis, including adverse effects.

    Method of Participation

    This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on June 10 & 11, 2023. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

    Rates


    image


    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ACCME Accreditation Statement:

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this live educational activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

     Schedule - Day 1 - All times Eastern Standard Time (NYC/USA)
    image


     Schedule - Day 2 -All times Eastern Standard Time (NYC/USA)

    image


    Sarah L. Morgan, MD, RD, CCD

    Professor, Medical Director UAB Osteoporosis Clinic and DXA Facility

    University of Alabama at Birmingham

    Dr. Morgan is the Medical Director of the University of Alabama at Birmingham Osteoporosis Prevention and Treatment Clinic and the UAB Bone Densitometry (DXA) Service. The UAB DXA service is accredited by the International Society for Clinical Densitometry. She received degrees in Food and Nutrition and Dietetics and Food and Nutrition and Related Sciences at Iowa State University and completed medical school and an internal medicine internship and residency at the University of Iowa. She completed a Clinical Nutrition fellowship and a master’s degree in Clinical Nutrition at the University of Alabama at Birmingham. She currently is a Professor of Medicine and Nutrition Sciences in the Division of Clinical Immunology and Rheumatology. Dr. Morgan’s research interests are in the areas of folate and methotrexate metabolism in rheumatoid arthritis and bone densitometry and she participates in osteoporosis and DXA clinical trials in the UAB Osteoporosis Clinic. Dr. Morgan is s past President of the International Society for Clinical Densitometry and a past chair of the ISCD Education Council.

    Disclosures: No Financial Relationships to Disclose

    Steven M. Petak, MD, JD, MACE, FACP

    Division Head and Clinical Service Chief Endocrinology

    Houston Methodist Hospital

    Dr. Steven Petak is a clinical and academic endocrinologist in Houston, Texas.

    He is a past president of the American Association of Clinical Endocrinologists, the American College of Endocrinology (www.aace.com), and the International Society for Clinical Densitometry (www.iscd.org). He is an associate clinical professor at Weill-Cornell Medical College at the Houston Methodist Hospital and is the division head of endocrinology, diabetes and metabolism as well as service chief of endocrinology. He is a bone densitometry and endocrine consultant to NASA at the Johnson Space Center for about 13 years and has been a part of the bone summit planning long duration space missions. He is the secretary of the board of councilors of the Texas Medical Association (2015) and represents the Harris County Medical Society as vice-councilor.

    His awards include Master of the American College of Endocrinology, Yank Coble Public Service Award of the American College of Endocrinology, the ISCD Paul Miller Public Service Award, and ISCD Clinician of the Year. He has authored and co-authored articles, editorials and guidelines in endocrinology and reproductive medicine.

    He received his MD from the University of Illinois in Chicago and has his JD from the University of Houston (Magna cum Laude). He had his internship, residency, medical chief residency, and fellowship in endocrinology and metabolism at the University of Texas at Houston. He was at the Texas Institute for Reproductive Medicine and Endocrinology in Houston for about 26 years before joining the academic endocrine group at Methodist in May 2013. He is board certified in internal medicine as well as endocrinology and metabolism.

    Disclosures: Fees for Non-CME Services: Amgen, Alexion, Shire, Alexion 

    Gillian Wooldridge, DO, CCD

    Gillian Wooldridge is a primary care sports medicine physician in Houston, Texas. She completed her undergraduate studies in Kinesiology-Sports Medicine at Rice University in 2009. She received her medical degree from the Texas College of Osteopathic Medicine in 2014, where she was the inaugural recipient of the Sports Medicine Achievement Award. Dr Wooldridge completed her family medicine residency in 2017 and sports medicine fellowship in 2018, with Houston Methodist and Houston Methodist Willowbrook Hospitals respectively. 

    She currently works for Houston Methodist Orthopedics and Sports Medicine in the Texas Medical Center. She serves as a team physician for Rice University Athletics and volunteers with several organizations in the community including the Chevron Houston Marathon, IronMan Texas and the Houston Livestock Show and Rodeo. Dr Wooldridge is a member of the board of directors for the American Osteopathic Academy of Sports Medicine and is actively involved in the American Medical Society of Sports Medicine as an item writer for the sports medicine in-training exam. 

    She is a certified clinical densitometrist and works on the Osteoporosis Essentials Course Committee and serves as a co-director of the Bone Health Initiative in the Houston Methodist Orthopedics and Sports Medicine department. She holds a core clinical faculty position with the Texas A&M College of Medicine Engineering & Medicine program and a clinical faculty position the Tillman Fertitta Family College of Medicine. 

    Disclosures: No Financial Relationships to Disclose

    Course Planning Committee

    Neil Binkley, MD, CCD, CBDT  Consulting Fee: Amgen; Contracted Research: Radius 
    Sarah Morgan, MD, RD< CCD No Financial Relationships to Disclose 
    Steven Petak, MD, JD, MACE, FACP, CCD Fees for Non-CME Services: Amgen, Alexion
    Christopher Shuhart, MD, CCD No Financial Relationships to Disclose
    S. Bobo Tanner, MD, CCD Consulting Fees: AMDA, CSL Behring, Radius, Ultragenyx; Fees for Non-CME Services: Regeneron, Sanofi/GENZYME; Contracted Research: Amgen 

    Course Content Reviewers

    Carolyn Crandall, MD, CCD No Financial Relationships to Disclose 
    Monique Carroll, RT, CBDT No Financial Relationships to Disclose 
    Brian Englander, MD No Financial Relationships to Disclose 
    Ranjodh Gill, MD, CCD No Financial Relationships to Disclose 
    Heidi Kecskemethy, MS Ed, RDN, CSP, CBDT No Financial Relationships to Disclose
    Adrian Lau, MD, FRCPC, MScCH, CCD No Financial Relationships to Disclose 
    Orhan Oz, MD, PhD, CCD  No Financial Relationships to Disclose

    June 2023 Course Faculty

    Sarah Morgan, MD, RD, CCD No Financial Relationships to Disclose
    Steven M. Petak, MD, JD, MACE, FACP Fees for Non-CME Services: Amgen, Alexion
    Gillian G. Woolridge, DO, CCD No Financial Relationships to Disclose

    image

    Statement of independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

  • Includes Multiple Live Events. The next is on 04/01/2023 at 1:00 PM (CDT)

    Course Date: April 1, 2023. This course focuses on increasing the knowledge and competence of clinicians and other healthcare professionals to help them successfully use DXA body composition analysis in the management of obesity, geriatric sarcopenia and other low muscle mass states, general health and pediatric skeletal disease. The inclusion of case studies will reinforce the knowledge gained and allow for application in the diagnosis, treatment and therapies of patients presenting with low bone mineral density.

    Course Date

    April 1, 2023

    Course Description

    This course focuses on increasing the knowledge and competence of clinicians and other healthcare professionals to help them successfully use DXA body composition analysis in the management of obesity, geriatric sarcopenia and other low muscle mass states, general health and pediatric skeletal disease. The inclusion of case studies will reinforce the knowledge gained and allow for application in the diagnosis, treatment and therapies of patients presenting with low bone mineral density.

    Target Audience

    The content is designed for healthcare providers responsible for reading and interpreting DXA scans, including specialists and generalists working in family medicine, general and internal medicine, rheumatology, endocrinology, obstetrics/gynecology, radiology, physical and occupational therapy, and research, as well as technologists.

    Learning Objectives

    After attending the course, participants should be better prepared to:

    1. Identify proper DXA technology for body composition analysis of fat, lean muscle and bone mass.
    2. List other methods of body composition analysis used in the clinical setting.
    3. Differentiate reference values and indices.
    4. Identify limitations of reference values and indices.
    5. Summarize scan acquisition for adult and pediatric patients.

    Method of Participation

    This activity will be offered in person, allowing the learners and faculty members to interact in a live, in-person, format on April 1, 2023. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit. 

    Rates

    image

    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ACCME Accreditation Statement:

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this live educational activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ASRT Credit Designation: 

    This activity has been approved by ASRT for 4.5 Category A continuing education credits.

    Date of Original Release and most recent Review or Update: This activity was most recently reviewed and released on July 25, 2022.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

    Schedule - April 1, 2023 - All times central (CHI/USA)
    image

    Hotel & Local Transportation

    image

    Renaissance Chicago North Shore Hotel

    933 Skokie Boulevard, Northbrook, Il 60062
    Phone: 1-847-498-6500

    ISCD has negotiated the following nightly rates for attendees. ISCD room rates are available March 28 to April 3. Click here to reserve your room at the discounted group rate. Discounted rates will be available until March 13, 2023. Single Traditional Guest Room: $119 plus tax - Traditional room options include one king or two queen beds. Visit Renaissance Chicago North Shore Hotel for more details on the hotel and amenities.  

    imageReserve your room at the ISCD discounted rate by March 13.

    imageAirport Information

    O'Hare International Airport

    Airport Phone +1 (800) 832-6352
    Website https://www.flychicago.com/oha...
    Hotel direction:  18 miles North

    image Transportation from Airport to Hotel

    There is no hotel shuttle available from the airport. Below are the recommended transportation options for getting from the airport to the hotel.

    image Hotel Parking

    Complimentary On-Site Parking Long Term Parking

    image Hotel Shuttle

    The hotel offers a complimentary shuttle anywhere within 5 miles of the hotel. The shuttle runs daily from 7am until 11pm. 

    image Transportation from Hotel to Downtown Chicago

    The hotel shuttle offers service to the Glencoe Station Metra stop which can be taken all the way south until the end of the line which is Ogilvie Transportation Center (OTC).

    Greg Yardley

    Sr. Medical Radiology Technologist and Researcher, NASA

    NASA Bone Mineral Laboratory

    Greg Yardley works as a SR. Medical Radiology Technologist and researcher in the NASA Bone Mineral Laboratory and NASA/JSC medical clinic for KBR in the government solutions division. His job requirements are performing and analyzing, Dual Energy x-ray absorptiometry (DXA) exams on both retired and active Astronauts. He also extracts, records, aids in bone density interpretation and distributes bone data from Dual Energy xray absorptiometry (DXA), Computed Tomography (CT), Magnetic resonance imaging devises. Greg also performs diagnostic medical x-rays for the NASA/JSC Flight medicine and occupational health clinic. 

    Greg began his healthcare career as an Emergency Medical Technician (EMT). He then furthered his medical education and received his certification as a registered radiology technologist. Upon completion of his Radiological Science courses. Greg has worked as a Radiology technologist in a Trauma level 1 Hospital, Level III hospital, urgent care, and multi-specialty clinic. At the time of his graduation Greg had also received extensive training not only in X-ray but also DXA, CT, and Ultrasound. In 2011 just previous to his current job Greg got a job as a Bone Density Technologist at a multi-specialty medical clinic where he performed and analyzed over 3000 DXA scans a year on every type of patient imaginable while also running the day-to-day operations of the Osteoporosis center.

    Disclosure: No Financial Relationships to disclose.

    Adam Kuchnia

    Adam Kuchnia is an Assistant Professor at the University of Wisconsin-Madison in the Department of Nutritional Sciences and holds a joint appointment within the Department of Surgery at the University of Wisconsin School of Medicine and Public health. The overall goal of his laboratory is to use a translational research approach to understand the mechanisms involved in the pathogenesis and the clinical implications of myosteatosis (i.e. muscle quality), or the infiltration of fat within muscle tissue, in aging and age-related disease. He has expertise in various imaging modalities for the assessment of muscle and in protein/muscle metabolism. Currently, his research focuses on human nutrition, in vivo lean tissue/muscle imaging and ex vivo measures to assess muscle and metabolic dysfunction. Adam is particularly interested in novel applications to refine protein recommendations with the goal of preserving muscle mass and muscle quality, while preventing consequential outcomes seen in aging and age-related disease. His research also aims to develop novel, noninvasive methods to accurately detect muscle wasting and myosteatosis and monitor changes in skeletal muscle while optimizing therapeutic intervention throughout medical treatment and surgery, including chemotherapy/immunotherapy and transplantation.

    No financial relationships to disclose

    Course Planning Committee

    Ian Entwistle No Financial Relationships to Disclose
    Karen Hind, PhD, No Financial Relationships to Disclose
    Gary Slater No Financial Relationships to Disclose
    Michelle Swainson, BSc, MSc, PhD No Financial Relationships to Disclose
    Greg Yardley, MSRS, RT(R), CBDT No Financial Relationships to Disclose

    Course Content Reviewers

    Suresh Kumar, MD, CCD No Financial Relationships to Disclose
    William Leslie, MD, FRCPC, MSc, CCD No Financial Relationships to Disclose
    Kelly Molinar-Kagan, RT(R)(M), CBDT No Financial Relationships to Disclose
    Vani Selvan, MD, CCD No Financial Relationships to Disclose

    March 2023 Course Faculty

    Adam Kuchina No Financial Relationships to Disclose
    Greg Yardley, MSRS, RT(R), CBDT No Financial Relationships to Disclose
    Dr. John A. Shepherd, PhD, CCD Contracted Research- Hologic, Inc-Investigator Initiated Study; GE Healthcare-Investigator Initated Study; Ownership Interest-BodySpec-Stock Options for Scientific Advisory Board

    image

    Statement of independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

  • Treatments for Osteoporosis: Combination or Sequence? Does Order Matter?

    Activity approved for 1.5 ASRT Category A Credits
    Activity approved for up to 1.0 AMA PRA Category 1 Credits™
    Activity Expires December 31, 2023

    Activity Description

    Treatments for Osteoporosis: Combination or Sequence? Does Order Matter?

    Learning Objectives

    1. The attendee should understand that anabolic treatment is most effective when given ab initio, before antiresorptive treatment
    2. The attendee should understand that anabolic treatments must be followed by antiresorptives to avoid losing all the gain
    3. The attendee should understand that with certain specific exceptions, antiresorptives should not be given concurrently with anabolics.

    Instructions

    Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

    Registration Fees

    image

    Cancellation Policy

    On-Demand/ Enduring Material Cancellation Purchases of on-demand or enduring educational materials are non-refundable. 

    On-Demand/Enduring Material Program Changes or Cancellations  ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

    ACCME Accreditation Statement

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ASRT Credit Designation 

    This activity has been approved by ASRT for 1.50 Category A continuing education credits.

    Date of Original Release and most recent Review or Update 

    This activity was most recently reviewed and released on December 21, 2022, and will expire on December 31, 2023

    Nelson B. Watts, MD, FACP, MACE, CCD

    Director, Osteoporosis and Bone Health Services

    Mercy Health, Cincinnati OH

    Nelson B. Watts, MD, FACP, MACE, CCD, currently serves as Director of Osteoporosis and Bone Health Services for Mercy Health, an integrated health system in Cincinnati, Ohio. He has a long career in osteoporosis research at Emory University and the University of Cincinnati. He has served as President of the American College of Endocrinology, President of the International Society of Clinical Densitometry, Chair of the FDA’s Advisory Committee for Endocrine and Metabolic Drugs and on the ABIM subspecialty board in Endocrinology and Metabolism. He is active in numerous professional organizations and serves on several editorial boards. He has published numerous, books, book chapters, abstracts and articles in such journals as the New England Journal of Medicine and the Journal of the American Medical Association.

    Disclosures: 

    Amgen and Radius (Self) : Speaker's Bureau / Teaching Engagements (Status: Ongoing)

    Jennifer Kelly, DO, FACE, CCD

    Director of the Metabolic Bone Program

    University Of Vermont

    Disclosures: No relationships to disclose.

    Course Planners and Managers

    Harold Rosen, MD, CCD No Financial Relationships to Disclose
    Wendy Tolman-Andrews, CBDT No Financial Relationships to Disclose
    Peter Brown, MS No Financial Relationships to Disclose
    Jesse Palmer No Financial Relationships to Disclose

    Course Content Reviewers

    William Leslie, MD, FRCPC, MSc, CCD No Financial Relationships to Disclose

    Course Faculty, Moderators, and Content Authors

    Nelson B. Watts, MD, FACP, MACE, CCD : Amgen and Radius (Self) : Speaker's Bureau / Teaching Engagements (Status: Ongoing)
    Jennifer Kelly, DO, FACE, CCD : No Financial Relationships to Disclose

    image

    Statement of Independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use 

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendee Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program. 

  • FRAX has been available since 2008 and is widely used worldwide. This lecture will provide a background to FRAX, its potential and limitations, and ongoing efforts to update the FRAX tool. These updates range from taking account of less-validated risk factors (adjustments) to a full redevelopment of the FRAX risk factor calculation engine.

    Activity approved for 1.25 ASRT Category A Credits
    Activity approved for up to 1.25 AMA PRA Category 1 Credits™
    Activity Expires September 1, 2023

    Activity Description

    FRAX has been available since 2008 and is widely used worldwide. This lecture will provide a background to FRAX, its potential and limitations, and ongoing efforts to update the FRAX tool. These updates range from taking account of less-validated risk factors (adjustments) to a full redevelopment of the FRAX risk factor calculation engine.

    Learning Objectives

    1. The attendee should understand the factors that go into the FRAX calculation 
    2. The attendee should understand the limitations of the current FRAX calculator 
    3. The attendee should understand the value of the enhancements that have already been done to FRAX, and those proposed. 
    4. Identify basis of fracture probability compared to fracture risk 
    5. Explain the minimum requirements for inclusion of risk factors within FRAX 
    6. Describe the potential use of adjustments to FRAX probabilities 

    Instructions

    Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

    Registration Fees

    image

    Cancellation Policy

    On-Demand/ Enduring Material Cancellation
    Purchase of on-demand or enduring educational materials are non-refundable.

    On-Demand/Enduring Material Program Changes or Cancellations 
    ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

    ACCME Accreditation Statement 

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ASRT Credit Designation 

    This activity has been approved by ASRT for 1.25 Category A continuing education credits.

    Date of Original Release and most recent Review or Update 

    This activity was most recently reviewed and released on August 11, 2022, and will expire on September 1, 2023

    Eugene McCloskey, MD

    University of Sheffield Metabolic Bone Centre

    Eugene McCloskey is Professor in Adult Bone Diseases in the Academic Unit of Bone Metabolism and Mellanby Centre for Musculoskeletal Research at the University of Sheffield; and Director of the MRC Versus Arthritis Centre for Integrated Research in Musculoskeletal Ageing (www.CIMAuk.org). He has published over 430 peer-reviewed publications, book chapters and reviews and is an acknowledged authority in the fields of vertebral fracture definition, osteoporosis epidemiology and treatment, fracture risk assessment and bone health in cancer. He contributed to the development of the FRAX tool and the subsequent guideline from the National Osteoporosis Guideline Group. Professor McCloskey is on a number of editorial boards and is a member of committees within organisations including the boards of IOF and ESCEO. He is also the past President of the Bone Research Society. In 2016, he was awarded the IOF Medal of Achievement, presented annually to recognise an individual researcher who has significantly advanced the field of osteoporosis through original and outstanding scientific contributions. In 2018, he was honoured with the ECTS Philippe Bordier Award for a significant clinical contribution to the field of bone and calcified tissue.

    Disclosures: 

    Consulting Fee (Amgen, Fresenius Kabi, ObsEva, UCB); Fees for Non-CME Services (Speaker Honoraria from Amgen, UCB); Contracted Research (Amgen, Consilient Health, ObsEva, UCB)

    Kaitlyn Barrett, DO (Moderator)

    Endocrinologist

    The University of Vermont Medical Center

    Kaitlyn Barrett, DO, is an Endocrinologist and Assistant Professor at the University of Vermont Medical Center and Larner College of Medicine where she also serves as the Associate Program Director of the Endocrine Fellowship Program. She completed her endocrine fellowship and internal medicine residency training at UVMMC, and recieved her medical degree from New York Institute of Technology College of Osteopathic Medicine in 2014. Clinical interests include osteoporosis and calcium disorders, diabetes and cardiometabolic disease.

    Disclosures: No relationships to disclose.

    Course Planners and Managers

    Harold Rosen, MD, CCD No Financial Relationships to Disclose
    Wendy Tolman-Andrews, CBDT No Financial Relationships to Disclose
    Peter Brown, MS No Financial Relationships to Disclose
    Jesse Palmer No Financial Relationships to Disclose

    Course Content Reviewers

    S. Kumar, MD, CCD No Financial Relationships to Disclose

    Course Faculty, Moderators, and Content Authors

    Eugene McClosky, MD - Consulting Fee (Amgen, Fresenius Kabi, ObsEva, UCB); Fees for Non-CME Services (Speaker Honoraria from Amgen, UCB); Contracted Research (Amgen, Consilient Health, ObsEva, UCB)
    Kaitlyn Barrett, DO, Moderator - No Financial Relationships to Disclose

    image

    Statement of Independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use 

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record learner’s personal information as provided on evaluations to allow for issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendee Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program. 

  • Trabecular Bone Score (TBS) has recently become an additional analysis that can be undertaken using the DXA scans. The purpose of this lecture is to provide an overview of TBS, along with guidance in the short term, before there is an official ISCD position statement developed at the next annual meeting (2023).

    Activity approved for 1.0 ASRT Category A Credits 
    Activity approved for up to 1.0 AMA PRA Category 1 Credits™ 
    Activity Expires December 1, 2023

    Trabecular Bone Score (TBS) has recently become an additional analysis that can be undertaken using the DXA scans. The purpose of this lecture is to provide an overview of TBS, along with guidance in the short term, before there is an official ISCD position statement developed at the next annual meeting (2023). 

    Learning Objectives:

    1. A high-level overview of TBS and data supporting its use
    2. When and how TBS should be performed
    3. How TBS might be reported, and finally
    4. Consider the clinical use of TBS

    Instructions: Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

    image

    ACCME Accreditation Statement: The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™ The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ASRT Credit Designation: This activity is approved by ASRT for 1.0 Category A continuing education credits.

    Date of Original Release and most recent Review or Update: This activity was most recently reviewed and released on November 1, 2022, and will expire on December 1, 2023.

    Deadline to Claim Credit: Participants must complete the activity, the activity survey, and claim credits before the activity expiration date.

    Neil Binkley, MD, CCD

    Professor of Medicine

    University of Wisconsin-Madison

    Dr. Neil Binkley earned his medical degree from the University of Wisconsin and subsequently trained in Internal Medicine at the Marshfield Clinic. After several years in private practice, he returned to the University of Wisconsin and completed a Geriatrics fellowship. He is a Professor in the Divisions of Geriatrics and Endocrinology at the University of Wisconsin School of Medicine and Public Health. He is also Director of the UW Osteoporosis Clinical Research Program and Associate Director of the UW Institute on Aging. He is past President of the International Society for Clinical Densitometry, Associate Editor of Osteoporosis International and a member of the International Osteoporosis Foundation Committee of Scientific Advisors. His current research involves improvement in 25(OH)D measurement, evaluation of approaches to optimize assessment of vitamin D status, evaluation of functional assessment in older adults and the importance of sarcopenia in fracture risk. Dr. Binkley has published over 300 papers, served on expert committees and panels for AACE, ASBMR, IOF and ISCD.

    Disclosures: Amgen: Consultant; Radius: Research Support

    William Leslie, MD, MSc, CCD

    Professor of Medicine and Radiology

    University of Manitoba

    Dr. Leslie is Professor of Medicine and Radiology at the University of Manitoba with over 450 peer-reviewed publications. His research interests are in fracture risk assessment, osteoporosis testing and other nuclear diagnostic techniques. He is Past President of the International Society for Clinical Densitometry, Past Chair of the Osteoporosis Canada Scientific Advisory Council, co-led the “2010 Clinical Practice Guidelines in Osteoporosis”, Director of the Manitoba Bone Density Program, and Co-Director of the Winnipeg PET Imaging Centre.

    Disclosures: No relationships to disclose.

    Course Planners and Managers

    Campbell Macgregor - No Financial Relationships to Disclose

    Course Content Reviewers

    S. Kumar, MD, CCD -  No Financial Relationships to Disclose

    Course Faculty and Content Authors

    Dr Neil Binkley, MD - Amgen: Consultant; Radius: Research Support

    Dr William Leslie, MD - No Financial Relationships to Disclose

    Statement of independence
    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in course material. No Commercial Support has been provided for this activity

    Disclaimer 
    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use 
    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement
    The ISCD will record learner’s personal information as provided on evaluations to allow for issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy
    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations
    ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.